Crocs (NASDAQ:CROX) has been a roller-coaster of an investment, to say the least. From lows of $10 in 2020 to highs around $180 in 2021 and back under $50 again in 2022, the share price has bucked investors around like a wild bull at a county fair.
And despite falling far short of the market this year –
» Read more about: Market Commentary: 1 Growth Stock That Is Crushing Asia »
Investment Alert: Buy Coca Cola (KO) Under $59/share
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
A glance at Berkshire’s portfolio will reveal Coca-Cola as one of its heavyweight investments,
» Read more about: Alert: 1 Warren Buffett Stock To Buy Before Takeoff »
In my view, Verizon’s generous dividend isn’t just stable, it’s on track to climb even higher. As it stands, Verizon offers a tantalizing dividend yield of 7.9%, a figure amplified by the recent dip in its stock price. The stock has lost about a fifth of its value from its peak over the past 52 weeks,
» Read more about: Market Commentary: Is This 7.9% Dividend Real? »
Investment Alert: Buy Teladoc (TDOC) Under $23/share
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
When it comes to rewarding shareholders, Warren Buffett is a maestro. His behemoth of an investment firm, Berkshire Hathaway, manages over $380 billion in investments, mostly in companies with burgeoning dividends.
Just when we thought Onto Innovation had shared all its good news for the quarter, the semiconductor equipment manufacturer dropped another bombshell. Onto has raked in new equipment orders to the tune of more than $100 million.
What’s the catalyst behind this financial windfall?
» Read more about: Market Commentary: 1 Tiny AI Stock Seals $100M Deal »
Investment Alert: Buy Moderna (MRNA) Under $115/share
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
The global landscape shaped by the COVID-19 pandemic is gradually evolving.
» Read more about: Alert: 61.9% Upside Ahead of Flu Season »
Are you looking for predictable income that you can rely on through the various up and downs of the market? Better yet, what about a super safe dividend that pays out monthly to cover regular expenses?
Cathie Wood has been investing heavily in Verve Therapeutics (VERV), a company developing therapies for cardiovascular diseases. So what’s all the fuss about? We took a deeper dive to find out.
Investment Alert: Buy Chubb (CB) Under $205/share
